Kardiyovasküler Sistem ve Anjiotensin II Tip 2 Reseptörü (AT2)

ı.
Wrigh
t JW, Kiebs LT, Stobb JW, Harding JW. The Angiotensin IV system: Functional implications. Front Neuroendocrinol, ı995; ı6: 23-52.
2. Hanesworth JM, Sardinia MF, Krebs LT, Hall KL, Harding JW. Elucidation of a
specific binding site for angiotensin II (3-8), Angiotensin IV, in mammalian heart membranes. J Pharmacol Exp Ther, ı993; 266(2): ı036-ı053.
3. Benter LF, Ferrario CM, Morris M, Diz DL. Chronic intravenous angiotensin (ı-7) infusions activate antihypertensive mechanisms in spontaneously hypertensive rats. Am J Hypertens, ı994; 7(4): H22.
4. Touyz RM, Schiffrin EL. Signal Transduction Mechanisms Mediating the Physiological and Pathopysiological Actions of Angiotensin II in Vascular Smooth
Muscle Cells. Pharmacol Rev, 2000; 52: 64ı.
5. Gasparo MD, Catt KJ, Inagami JW, Wright JW, Unger TH. International union of pharmacology. XXIII. The Angiotensin II receptors. Pharmacol Rev, 2000; 52: 4ı5-
472.
6. Lazard D, Briendsutren MM, Villageois P, Mattei MG, Strosberg AD, Nahmias C.
Molecular characterization and chromosome localization of a human angiotensin II AT2 receptor gene highly expressed in fetal tissues. Receptors Channels, ı994; 2: 27ı-
280.
7. Horiuchi M, Akishita M, Dzau VJ. Recent progress in angiotensin II type 2 receptor research in the cardiovascular system. Brief Review, ı999; 33: 6ı3-62ı.
8. Gunter W. The road not taken: role of angiotensin II type receptor in
pathophysiology. Neprol Dial Transplant, 2002; ı7: ı95-ı98.
9. Schuijt MP, Basdew M, Van Veghel R, De Vries R, Saxena PR, Schoemaker RG, Jan
Danser AH. AT2 receptor-mediated vasodilation in the heart: effect of myocardial
infarction. Am J Physiol Heart Circ Physiol, 200ı; 28ı: H2590-H2596.
ı0.
Boo
z GW, Baker KM. Role of type ı and type 2 angiotensin receptors in in angiotensin II- induced cardiomyocyte hypertrophy. Hypertension, ı996; 28: 635-640.
ıı.
Ni
o Y, Matsuharj H, Muravuwa S, Kanasaki M, Inada M. Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. J Clin Invest, ı995; 95: 46-54.
ı2.
Lope
z J, Lorell BH, Ingelfinger JR Weinberg EO, Schunkert H, Diamant D, Tang SH. Distribution and function of cardiac angiotensin ATı-and AT2-receptor
subtypes in hypertrophied rat hearts. Am J Physiol, ı994; 36: H844-H852.
ı3.
Dza
u VJ, Horiuchi M. Differential expression of angiotensin receptor subtypes in the
myocardium: a hypothesis. Eur Heart J, ı996; ı7: 978-980. ı4. Haywood GA, Gullestad L, Katsuya T, Hutchinson HG, Pratt RE, Horiuchi M,
Fowler MB. ATı and AT2 receptor gene expression in human heart failure.
Circulation, ı997; 95:ı20ı-ı206. ı5. Liu Y-H, Yang X-P, Sharov VG, Nass O, Sabah HN, Peterson E, Carretero OA.
Effect of angiotensin-converting enzyme inhibitors and angiotensin II type I receptor antagonists in rats with heart failure. J Clin Invest, ı997; 99: ı926-ı935.
ı6.
Yamad
a T, Akishita M, Pollman M, Gibbsons GH, Dzau VJ, Horiuchi M.
Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis and antagonizes angiotensin type I receptor action: an in vitro gene transfer study. Life
Sci, ı998; 63: PL289-PL295.
ı7.
Masaki
, Kurihara T, Yamaki A, Inomata N, Nozawa Y, Mori Y, Murasawa S, Kizima K, Maruyama K, Horiuchi M, Dzau VJ, Takahashi H, Iwasaka T, Inada M, Matsubara H. Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to ATı receptor-mediated pressor and chronotropic effects. J Clin Invest,
ı998; ı0ı: 527-535.
ı8.
Busch
e S, Gallinat S, Bohle RM, Reinecke A, Seebeck J, Franke F, Fink L, Zhu M, Summers C, Unger T. Expression of ATı and AT2 receptors in adult rat cardiomyocytes after myocardial infarction: a single-cell RT-PCR study. Am J Pathol,
2000;
ı57
: 605-6ıı.
ı9.
Sech
i LA, Griffin CA, Grady EF, Kalinyak JE, Schambelan M. Distribution of
angiotensin II receptor subtypes in rat heart. Circ Res, ı992; 7ı: ı482-ı489.
20. Matsubara H, Kanasaki M, Murasawa S, Tsukaguchi Y, Nio Y, Inada M. Differential gene expression and regulation of angiotensin II receptor subtypes in rat cardiac fibroblasts and cardiomyocytes in culture. J Clin Invest, ı994; 93: ı592-ı60ı.
2ı.
Unge
r T. The angiotensin type 2 receptor: variations on an enigmatic theme. J
Hypertens,
ı999
; ı7: ı775-86.
22. Rogg H, de Gasparo M, Graedel E, Stulz P, Burkart F, Eberhard M, Erne P.
Angiotensin II receptor subtypes in human atria and evidence for alterations in patients with cardiac dysfunction. Eur Heart J, ı996; ı7: ııı2-ıı20.
23. Wharton J, Morgan K, Rutherford RA, Catravas JD, Chester A, Whitehead BF, De Leval MR, Yacoub MH, Polak JM.. Differential distribution of angiotensin AT2
receptors in normal and failing human heart. J Pharmacol Exp Ther, ı998; 284: 323¬336.
24. Ohkubo N, Matsubara H, Nozawa Y, Mori Y, Murasawa S, Kijima K, Maruyama K,
Masaki H, Tsutumi Y, Shibazaki Y, Iwasaka T, Inada M. Angiotensin type 2 receptors are reexpressed by cardiac fibroblasts from failing myopathic hamster hearts and inhibit cell growth and fibrillar collagen metabolism. Circulation, ı997; 96: 3954-3962.
25. Berry C, Touyz R, Dominiczak AF, Webb RC, Johns DG. Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide. Am J Physiol
Heart Circ Physiol, 200ı; 28ı: 2337-2365.
26. Matsubara H. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res, ı998; 83: ıı82-ıı9ı.
27. Moore AF, Heiderstadt NT, Huang E, Howell NL, Wang ZQ, Siragy H, Carey RM Selective inhibiton of the renal angiotensin type 2 receptor increases blood pressure in conscious rats. Hypertension, 200ı; 37: ı285-ı29ı.
28. Giasson E, Meloche S. Role of p70 S6 protein kinase in angiotensin II-induced protein synthesis in vascular smooth muscle cells. J Biol Chem, ı995; 270: 5225-523ı.
29. Barber MN, Sampey DB, Widdop RE. AT2 receptor stimulation enhances antihypertensive effect of ATı receptor antagonist in hypertensive rats. Hypertension,
ı999; 34: ııı2-ııı6.
30. Andreas J, Rainer S, Hilmar D, Matthias B, Gerde H, Fesc F. Infarct size reduction by ATı-receptor blockade through a signal cascade of AT2-receptor activation,
bradykinin and prostaglandins. J Am Coll Cardiol, ı998; 32: ı787-ı796. 3ı. Otsuka S, Sugano M, Makino N, Sawada S, Hata T, Niho Y. Interaction of mRNAs
for angiotensin II type ı and type 2 receptors to vascular remodeling in spontaneously hypertensive rats. Hypertension, ı998; 32: 467-472.
32. Tsutsumi Y, Matsubara H, Ohkubo N, Mori Y, Nozawa Y, Murasawa S, Kijima K,
Maruyama K, Masaki H, Moriguchi Y, Shibasaki Y, Kamihata H, Inada M, Iwasaka T. Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression. Circ Res, ı998; 83:
ı035-ı046.